Cargando…

Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19

Recent advances in the pathophysiologic understanding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has indicated that patients with severe coronavirus disease 2019 (COVID-19) might experience cytokine release syndrome (CRS), characterized by increased interleukin (IL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wei, Li, Yi-Xin, Jiang, Li-Jun, Chen, Qian, Wang, Tao, Ye, Da-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298494/ https://www.ncbi.nlm.nih.gov/pubmed/32580895 http://dx.doi.org/10.1016/j.tips.2020.06.007

Ejemplares similares

Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
por: Ni, Yanhong, et al.
Publicado: (2022)

Antagonizing cytokine-mediated JAK-STAT signaling by porcine reproductive and respiratory syndrome virus
por: Yang, Liping, et al.
Publicado: (2017)

JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
por: Gotthardt, Dagmar, et al.
Publicado: (2019)

A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
por: Wang, Dong-Ping, et al.
Publicado: (2023)

Human cytokines activate JAK–STAT signaling pathway in porcine ocular tissue
por: Fasler-Kan, Elizaveta, et al.
Publicado: (2013)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
por: Lokau, Juliane, et al.
Publicado: (2019)

The JAK/STAT signaling pathway: from bench to clinic
por: Hu, Xiaoyi, et al.
Publicado: (2021)

Targeting the tumor microenvironment: JAK-STAT3 signaling
por: Bournazou, Eirini, et al.
Publicado: (2013)

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
por: Ou, Alexander, et al.
Publicado: (2021)

JAK/STAT Pathway Targeting in Primary Sjögren Syndrome
por: Gandolfo, Saviana, et al.
Publicado: (2022)

Temporal transcriptome highlights the involvement of cytokine/JAK/STAT3 signaling pathway in the osteoinduction of BMSCs
por: Ru, Xiao, et al.
Publicado: (2023)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity
por: Ptacek, Jason, et al.
Publicado: (2021)

Cytokines Activate JAK–STAT Signaling Pathway in MG-63 Cells on Titanium and Zirconia
por: Mukaddam, Khaled, et al.
Publicado: (2022)

A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal
por: Chen, Chengjuan, et al.
Publicado: (2022)

Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release
por: Wang, Li, et al.
Publicado: (2007)

The potential roles of JAK/STAT signaling in the progression of osteoarthritis
por: Zhou, Qingluo, et al.
Publicado: (2022)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome
por: Li, Mucong, et al.
Publicado: (2023)

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
por: de Freitas, Renata Mendes, et al.
Publicado: (2015)

JAK inhibitor blocks COVID-19 cytokine–induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids
por: Nystrom, Sarah E., et al.
Publicado: (2022)

Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
por: Majoros, Andrea, et al.
Publicado: (2017)

Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling
por: Gajjela, Bharath Kumar, et al.
Publicado: (2022)

Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo
por: Chang, Yuqian, et al.
Publicado: (2023)

JAK/STAT signaling and human in vitro myogenesis
por: Trenerry, Marissa K, et al.
Publicado: (2011)

JAK-STAT signaling and myocardial glucose metabolism
por: Frias, Miguel A, et al.
Publicado: (2013)

The role of JAK-STAT signaling within the CNS
por: Nicolas, Celine S., et al.
Publicado: (2013)

JAK/STAT signaling in diabetic kidney disease
por: Liu, Yingjun, et al.
Publicado: (2023)

Andrographolide Inhibition of Th17-Regulated Cytokines and JAK1/STAT3 Signaling in OVA-Stimulated Asthma in Mice
por: Yu, Qian, et al.
Publicado: (2021)

An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
por: Campia, Ivana, et al.
Publicado: (2015)

Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
por: Musiu, Chiara, et al.
Publicado: (2021)

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013)

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
por: Hu, Qian, et al.
Publicado: (2023)

Targeting the JAK/STAT pathway in solid tumors
por: Qureshy, Zoya, et al.
Publicado: (2020)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
por: Xue, Chen, et al.
Publicado: (2023)

HLX affects cell cycle and proliferation in AML cells via the JAK/STAT signaling pathway
por: Zhu, Xia-Yin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7psri6ab2ft2j6k5p67h2cjtb2